Cancers 2011, 3(4), 4170-4190; doi:10.3390/cancers3044170

Transcription Inhibition as a Therapeutic Target for Cancer

* email and email
Received: 18 July 2011; in revised form: 14 November 2011 / Accepted: 16 November 2011 / Published: 23 November 2011
(This article belongs to the Special Issue Cancer Diagnosis and Targeted Therapy)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: During tumorigenesis the transformed cells lose their normal growth control mechanisms and become dependent on oncogenes’ products and pathways for survival. Treatments tailored to block the expression or function of transforming genes have shown efficacy in eliminating neoplastic cells. The mRNAs of many oncogenes, as well as regulators of other key processes such as cell proliferation, angiogenesis, and apoptosis, typically have shorter half-lives. Agents that impede mRNA synthesis are expected to selectively hinder the expression of these genes and, therefore, be detrimental to neoplastic cells that are physiologically dependent on them. In addition to exploiting the tumor cells’ dependency on short-lived transcripts, RNA-directed agents also take advantage of the differential sensitivity between transformed and non-transformed cells, as the cytotoxic effects of inhibiting RNA synthesis have not been seen in non-transformed cells. The abrogation of the formation of oncotranscripts provides a new concept in cancer therapeutics and numerous agents have been developed which are able to target transcription. The focus of this review is to give an overview of transcription and the different inhibitory strategies that target various aspects of the transcriptional process.
Keywords: transcription inhibitors; oncogene addiction; gene expression; ribonucleoside analogs; cyclin–dependent kinase inhibitors
PDF Full-text Download PDF Full-Text [542 KB, uploaded 23 November 2011 08:59 CET]

Export to BibTeX |

MDPI and ACS Style

Stellrecht, C.M.; Chen, L.S. Transcription Inhibition as a Therapeutic Target for Cancer. Cancers 2011, 3, 4170-4190.

AMA Style

Stellrecht CM, Chen LS. Transcription Inhibition as a Therapeutic Target for Cancer. Cancers. 2011; 3(4):4170-4190.

Chicago/Turabian Style

Stellrecht, Christine M.; Chen, Lisa S. 2011. "Transcription Inhibition as a Therapeutic Target for Cancer." Cancers 3, no. 4: 4170-4190.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert